Quick Answer
NYMOX PHARMACEUTICAL CORP reported Total Assets of $654.0 thousand for fiscal year 2024.
NYMOX PHARMACEUTICAL CORP Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2024 | $654.0K | +4.3% |
| 2023 | $627.0K | -61.4% |
| 2022 | $1.62M | +12.6% |
| 2021 | $1.44M | -66.8% |
| 2020 | $4.34M | -20.9% |
| 2019 | $5.49M | -32.0% |
| 2018 | $8.08M | +724.9% |
| 2017 | $979.0K | -52.4% |
| 2016 | $2.06M | +188.9% |
| 2015 | $712.0K | — |
- NYMOX PHARMACEUTICAL CORP showed an increase of +4.3% in Total Assets compared to the prior fiscal year.
- Over the 2015–2024 period, NYMOX PHARMACEUTICAL CORP’s total assets has declined by 8.1% (from $712.0 thousand to $654.0 thousand).
- The most recent figure is from NYMOX PHARMACEUTICAL CORP’s fiscal year 2024 report (Form 20-F), filed with the SEC on June 3, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: